Medical Management of Hemodynamically Unstable Sinoatrial Node Dysfunction in a Patient With Intracardiac Lymphoma
- PMID: 34396343
- PMCID: PMC8352225
- DOI: 10.1016/j.jaccao.2021.03.003
Medical Management of Hemodynamically Unstable Sinoatrial Node Dysfunction in a Patient With Intracardiac Lymphoma
Keywords: arrhythmia; cardiac masses; lymphoma; treatment.
Conflict of interest statement
Dr. Castillo has received research support and honoraria from Abbvie, Beigene, Janssen, Pharmacyclics, Roche, and TG Therapeutics. Dr. Nohria has received research support from Amgen and the Gelb Master Clinician Award and the Catherine Geoff Fitch Fund; and is a consultant for Takeda Oncology and AstraZeneca. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
Figures
References
-
- Lam K.Y., Dickens P., Chan A.C. Tumors of the heart. A 20-year experience with a review of 12,485 consecutive autopsies. Arch Pathol Lab Med. 1993;117:1027–1031. - PubMed
-
- Poterucha T., Kochav J., O’Connor D.S., Rosner G.F. Cardiac tumors: clinical presentation, diagnosis, and management. Curr Treat Options in Oncol. 2019;20:66. - PubMed
-
- Klatt E.C., Heitz D.R. Cardiac metastases. Cancer. 1990;65:1456–1459. - PubMed
-
- Cattranukulchai P., Puwanant S., Rungpradubvong V., Singhatanadgige S., Boonyaratavej S. Combined mechanism of refractory shock in primary cardiac lymphoma: a rare dilemma. Heart Lung Circ. 2014;23:160–163. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
